Needham & Company LLC reaffirmed their buy rating on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Tuesday morning,Benzinga reports. Needham & Company LLC ...
MIT License Copyright (c) 2024 FAR e.V. Permission is hereby granted, free of charge, to any person obtaining a copy of this software and associated documentation ...